The pharmaceutical company reported a consolidated net profit of Rs 293.56 crore in Q4 FY24, steeply higher than Rs 70.98 crore recorded in Q4 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
The pharmaceutical company reported a consolidated net profit of Rs 293.56 crore in Q4 FY24, steeply higher than Rs 70.98 crore recorded in Q4 FY23.
| Subscribe To Our Free Newsletter |
